MONTANARO, NICOLA
Dettaglio
MONTANARO, NICOLA
DIP. DI FARMACOLOGIA
Pubblicazioni
Risultati 1 - 20 di 67 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | A 3 year survey on the use of antibacterial agents in five Italian hospitals. | Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N. | 2008 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1.01 Articolo in rivista | - | |
2 | A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. | Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C....; Vaccheri A.; Montanaro N. | 2009 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 4.02 Riassunto (Abstract) | - | |
3 | Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage | Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Pont...i F.; Montanaro N. | 2007 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | - | |
4 | Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. | Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggia...ni G; Montanaro N. | 2006 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4.02 Riassunto (Abstract) | - | |
5 | Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy | Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N. | 2008 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | - | |
6 | An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. | Silvani MC; Bersaglia L; Poluzzi E; Motola D; Bottoni A; Strahinja P; Vargiu A; Vaccheri A; Monta...naro N. | 2007 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 4.02 Riassunto (Abstract) | - | |
7 | Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region | Sacripanti C; Piccinni C; Puccini A; Poluzzi E; Montanaro N | 2011 | 4.02 Riassunto (Abstract) | - | ||
8 | Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. | M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vacch...eri; N. Montanaro. | 2008 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4.02 Riassunto (Abstract) | - | |
9 | Antibiotic use in Italian hospitals 2002-2004. | Silvani MC; Poluzzi E; Motola D; Strahinja P; Vargiu A; Bersaglia L; Vaccheri A; Montanaro N. | 2006 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4.02 Riassunto (Abstract) | - | |
10 | Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures | Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti P.; Greg...ori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Caputi A.P.; Mazzaglia G. | 2011 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | Wiley Blackewell | 4.02 Riassunto (Abstract) | - |
11 | Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, | Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti .P; Greg...ori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Arcoraci V.; Caputi A.P.; Mazzaglia G. | 2011 | Società Italiana di Farmacologia | 4.02 Riassunto (Abstract) | - | |
12 | Le basi della farmacologia | Montanaro N.; Motola D.; Vaccheri A. | 2007 | Zanichelli | 5.01 Libro (Traduzione) | - | |
13 | Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases | Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A. ; De Ponti F.; ...Montanaro N. | 2010 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | Wiley Blackewell | 4.02 Riassunto (Abstract) | - |
14 | Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study | Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A.; De Ponti F.; M...ontanaro N. | 2011 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | - | |
15 | Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics | Silvani MC; Motola D; Poluzzi E; Strahinja P; Vargiu A; Biagi C; Vaccheri A; Montanaro N. | 2007 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 4.02 Riassunto (Abstract) | - | |
16 | Un commento alla lettera sulla definizione di farmaco innovativo | Motola D.; Montanaro N. | 2012 | PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES | 1.01 Articolo in rivista | - | |
17 | Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions | C. Biagi;V. Conti;N. Montanaro;M. Melis;E. Buccellato;M. Donati;A. Covezzoli;R. Amato;L. Pazzi;M.... Venegoni;A. Vaccheri;D. Motola | 2014 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | - | |
18 | Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. | Voci C; Sangiorgi Cellini G; Silvani C; Poluzzi E; Vargiu A; Vaccheri A; Montanaro N. | 2004 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4.02 Riassunto (Abstract) | - | |
19 | Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database | Chiara Biagi;Mauro Venegoni;Mauro Melis;Elena Buccellato;Nicola Montanaro;Domenico Motola | 2013 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | - | |
20 | Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. | Leone R.; Conforti A.; Venegoni M.; Motola D.; Moretti U.; Meneghelli I.; Cocci A.; Sangiorgi Cel...lini G.; Scotto S.; Montanaro N.; Velo G. | 2005 | DRUG SAFETY | 1.01 Articolo in rivista | - |